Leer esta página en Español

B.1.1.7 Variant surveillance

Over the past weeks, variants of SARS-CoV-2 isolated in the United Kingdom (UK; lineage B.1.1.7) and South Africa (B.1.177) were associated with increased incidence of COVID-19. Our group, in collaboration with the Connecticut Department of Health, has intensified the genomic surveillance of the B.1.1.7 variant of SARS-CoV-2 in our region. We detected the new variant on January 7, 2021.

Read the latest report →

We are screening for possible variants by PCR using the protocol below.

See the qPCR protocol (in development) →

Yale SARS-CoV-2 Surveillance Initiatives

We’re using a variety of tools, including viral sequencing, case surveillance, test development, and wastewater surveillance, in order to learn more about how SARS-CoV-2 is spreading in Connecticut.



Genomes published


Current Reports

Paper: SalivaDirect

Our paper with the methods and data supporting our new cheap & flexible SARS-CoV-2 test method, SalivaDirect, is now available as a preprint. Read more →